May 28 (Reuters) - NextCell Pharma AB NXTCL.ST :
* SINGLE TREATMENT WITH PROTRANS DEMONSTRATES LONG-TERM
THERAPEUTIC EFFECT OVER 5 YEARS
* NO SERIOUS ADVERSE REACTIONS RELATED TO TREATMENT HAVE
BEEN
REPORTED
* WILL PRESENT MORE DETAILED RESULTS IN COMING WEEKS
* PROTRANS TREATED PATIENTS MAINTAINED 57% OF THEIR
ENDOGENOUS
INSULIN PRODUCTION COMPARED TO 15% IN PLACEBO GROUP
Source text for Eikon: ID:nWkr4FjnVk
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))